银屑病与非酒精性脂肪性肝病之间因果关系:双向双样本孟德尔随机化研究
Causal Relationship between Psoriasis and Non-Alcoholic Fatty Liver Disease: A Bidirectional Two-Sample Mendelian Randomization Study
DOI: 10.12677/acm.2024.144994, PDF,   
作者: 杨 恒:山东大学附属公共卫生临床中心消化科,山东 济南
关键词: 银屑病非酒精性脂肪性肝病孟德尔随机化因果关系Psoriasis NAFLD Mendelian Randomization Causal Relationship
摘要: 目的:采用孟德尔随机化(MR)研究银屑病与非酒精性脂肪性肝病之间的双向因果关系。方法:我们使用来自银屑病和NAFLD的汇总GWAS数据进行了双样本孟德尔随机化(TSMR)分析。选择满足孟德尔随机化三个核心假设的工具变量(IV)。TSMR分析采用逆方差加权(IVW)法为主要分析方法进行分析,辅以MR-Egger回归法和加权中位数(WM)法进行。为确保研究结果的准确性和稳定性,进行了异质性检验、多重有效性检验和敏感性分析。结果:IVW方法提示银屑病与非酒精性脂肪性肝病之间有因果关系(OR 1.20;95%可信区间:1.10~1.32;P = 9.58 × 105)。MR-Egger回归未显示有水平多效性。Cochran-Q检验结果表明纳入分析的SNP之间不存在异质性,MR-PRESS0检验未发现离群的SNP,“留一法”敏感性分析显示,因果估计不太可能受到某些SNP效应的影响,反向MR分析的结果表明非酒精性脂肪性肝病增加银屑病患病率。结论:银屑病与非酒精性脂肪性肝病之间存在因果关系。
Abstract: Objective: Mendelian randomization (MR) was used to investigate the bidirectional causal relationship between psoriasis and non-alcoholic fatty liver disease (NAFLD). Method: We performed a two-sample Mendelian randomization (TSMR) analysis using pooled GWAS data from psoriasis and NAFLD. Instrumental variables (IVs) were selected to satisfy the three core assumptions of Mendelian randomization. TSMR analyses were performed using the inverse variance weighting (IVW) method as the primary analytical method for the analyses, supplemented by MR-Egger regression and weighted median (WM) methods. Heterogeneity test, multiple validity test and sensitivity analysis were conducted to ensure the accuracy and stability of the findings. Results: The IVW method suggested a causal association between psoriasis and non-alcoholic fatty liver disease (OR 1.20; 95% confidence interval: 1.10~1.32; P = 9.58 × 105). MR-Egger regression did not show horizontal pleiotropy. The results of Cochran’s Q-test showed no heterogeneity between the SNPs included in the analysis, MR-PRESSO found no outlier SNPs, leave-one-out sensitivity analyses showed that causal estimates were unlikely to be affected by certain SNP effects, and the results of inverse MR analyses showed that NAFLD increased the prevalence of psoriasis. Conclusion: There is a causal relationship between psoriasis and non-alcoholic fatty liver disease.
文章引用:杨恒. 银屑病与非酒精性脂肪性肝病之间因果关系:双向双样本孟德尔随机化研究[J]. 临床医学进展, 2024, 14(4): 101-108. https://doi.org/10.12677/acm.2024.144994

参考文献

[1] Parisi, R., Iskandar, I.Y.K., Kontopantelis, E., Augustin, M., Griffiths, C.E.M., Ashcroft, D.M. and Global Psoriasis Atlas (2020) National, Regional, and Worldwide Epidemiology of Psoriasis: Systematic Analysis and Modelling Study. BMJ, 369, M1590. [Google Scholar] [CrossRef] [PubMed]
[2] Griffiths, C.E. and Barker, J.N. (2007) Pathogenesis and Clinical Features of Psoriasis. The Lancet, 370, 263-271. [Google Scholar] [CrossRef
[3] Boehncke, W.H. and Schön, M.P. (2015) Psoriasis. The Lancet, 386, 983-994. [Google Scholar] [CrossRef
[4] Younossi, Z.M., Koenig, A.B., Abdelatif, D., Fazel, Y., Henry, L. and Wymer, M. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology, 64, 73-84. [Google Scholar] [CrossRef] [PubMed]
[5] Younossi, Z.M. (2019) Non-Alcoholic Fatty Liver Disease—A Global Public Health Perspective. Journal of Hepatology, 70, 531-544. [Google Scholar] [CrossRef] [PubMed]
[6] Candia, R., Ruiz, A., Torres-Robles, R., Chávez-Tapia, N., Méndez-Sánchez, N. and Arrese, M. (2015) Risk of Non-Alcoholic Fatty Liver Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis. Journal of the European Academy of Dermatology and Venereology, 29, 656-662. [Google Scholar] [CrossRef] [PubMed]
[7] Gau, S.Y., Huang, K.H., Lee, C.H., Kuan, Y.H., Tsai, T.H. and Lee, C.Y. (2022) Bidirectional Association between Psoriasis and Nonalco-Holic Fatty Liver Disease: Real-World Evidence from Two Longitudinal Cohort Studies. Frontiers in Immunology, 13, Article ID: 840106. [Google Scholar] [CrossRef] [PubMed]
[8] Davey, S.G. and Hemani, G. (2014) Mendelian Randomization: Genetic Anchors for Causal Inference in Epidemiological Studies. Human Molecular Genetics, 23, R89-R98. [Google Scholar] [CrossRef] [PubMed]
[9] Chen, L., Fan, Z., Sun, X., et al. (2022) Mendelian Randomization Rules out Causation between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology, 13, Article ID: 891410. [Google Scholar] [CrossRef] [PubMed]
[10] Yavorska, O.O. and Burgess, S. (2017) Mendelian Randomization: An R Package for Performing Mendelian Randomization Analyses Using Summarized Data. International Journal of Epidemiology, 46, 1734-1739. [Google Scholar] [CrossRef] [PubMed]
[11] Pierce, B.L. and Burgess, S. (2013) Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators. American Journal of Epidemiology, 178, 1177-1184. [Google Scholar] [CrossRef] [PubMed]
[12] Burgess, S. and Thompson, S.G. (2017) Interpreting Findings from Mendelian Randomization Using the MR-Egger Method. European Journal of Epidemiology, 32, 377-389. [Google Scholar] [CrossRef] [PubMed]
[13] Egger, M., Smith, G.D. and Phillips, A.N. (1997) Meta-Analysis: Principles and Procedures. BMJ, 315, 1533-1537. [Google Scholar] [CrossRef] [PubMed]
[14] Verbanck, M., Chen, C.Y., Neale, B., et al. (2018) Detection of Widespread Horizontal Pleiotropy in Causal Relationships Inferred from Mendelian Randomization between Complex Traits and Diseases. Nature Genetics, 50, 693-698. [Google Scholar] [CrossRef] [PubMed]
[15] Bowden, J., Del Greco, M.F., Minelli, C., et al. (2016) Assessing the Suitability of Summary Data for Two-Sample Mendelian Ran-Domization Analyses Using MR-Egger Regression: The Role of the I2 Statistic. International Journal of Epidemiology, 45, 1961-1974. [Google Scholar] [CrossRef] [PubMed]
[16] Higgins, J.P. and Thompson, S.G. (2002) Quantifying Heterogeneity in a Meta-Analysis. Statistics in Medicine, 21, 1539-1558. [Google Scholar] [CrossRef] [PubMed]
[17] Burgess, S., Thompson, S.G. and CRP CHD Genetics Collaboration (2011) Avoiding Bias from Weak Instruments in Mendelian Randomization Studies. International Journal of Epidemiology, 40, 755-764. [Google Scholar] [CrossRef] [PubMed]
[18] Näslund-Koch, C., Bojesen, S.E., Gluud, L.L., Skov, L. and Vedel-Krogh, S. (2022) Non-Alcoholic Fatty Liver Disease Is Not a Causal Risk Factor for Psoriasis: A Mendelian Randomization Study of 108,835 Individuals. Frontiers in Immunology, 13, Article ID: 1022460. [Google Scholar] [CrossRef] [PubMed]
[19] Mantovani, A., Gisondi, P., Lonardo, A. and Targher, G. (2016) Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis? International Journal of Molecular Sciences, 17, Article No. 217. [Google Scholar] [CrossRef] [PubMed]
[20] Heitmann, J., Frings, V.G., Geier, A., Goebeler, M. and Kerstan, A. (2021) Non-Alcoholic Fatty Liver Disease and Psoriasis—Is There a Shared Proinflammatory Network? Journal der Deutschen Dermatologischen Gesellschaft, 19, 517-528. [Google Scholar] [CrossRef] [PubMed]
[21] Diehl, A.M. (2004) Tumor Necrosis Factor and Its Potential Role in Insulin Resistance and Nonalcoholic Fatty Liver Disease. Clinical Liver Disease, 8, 619-638. [Google Scholar] [CrossRef] [PubMed]
[22] Xue, K., Liu, H., Jian, Q., Liu, B., Zhu, D., Zhang, M., Gao, L. and Li, C. (2013) Leptin Induces Secretion of Pro-Inflammatory Cytokines by Human Keratinocytes in Vitro—A Possible Reason for Increased Severity of Psoriasis in Patients with a High Body Mass Index. Experimental Dermatology, 22, 406-410. [Google Scholar] [CrossRef] [PubMed]
[23] Neuschwander-Tetri, B.A. (2010) Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: The Central Role of Nontriglyceride Fatty Acid Metabolites. Hepatology, 52, 774-788. [Google Scholar] [CrossRef] [PubMed]
[24] Carter-Kent, C., Zein, N.N. and Feldstein, A.E. (2008) Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steato-Hepatitis: Implications for Treatment. American Journal of Gastroenterology, 103, 1036-1042. [Google Scholar] [CrossRef] [PubMed]
[25] Byrne, C.D. and Targher, G. (2015) NAFLD: A Multisystem Disease. Journal of Hepatology, 62, S47-S64. [Google Scholar] [CrossRef] [PubMed]
[26] Prussick, R.B. and Miele, L. (2018) Nonalcoholic Fatty Liver Disease in Patients with Psoriasis: A Consequence of Systemic Inflammatory Burden? British Journal of Dermatology, 179, 16-29. [Google Scholar] [CrossRef] [PubMed]
[27] Wijarnpreecha, K., Aby, E.S., Ahmed, A. and Kim, D. (2021) Evaluation and Management of Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Clinical and Molecular Hepatology, 27, 221-235. [Google Scholar] [CrossRef] [PubMed]
[28] Byrne, C.D. and Targher, G. (2014) Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease: Implications for Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1155-1161. [Google Scholar] [CrossRef
[29] Stefan, N. and Häring, H.U. (2013) The Role of Hepatokines in Metabolism. Nature Reviews Endocrinology, 9, 144-152. [Google Scholar] [CrossRef] [PubMed]